易瑞生物股价上涨6.43% 公司更换持续督导保荐代表人

Core Viewpoint - The stock price of Yirui Biotech has increased by 6.43% to 13.08 yuan, indicating positive market sentiment towards the company [1] Company Overview - Yirui Biotech operates in the chemical pharmaceutical industry, focusing on the research, production, and sales of in vitro diagnostic products [1] - The company's product range includes infectious disease testing, drug testing, and food safety testing [1] Stock Performance - The stock opened at 12.30 yuan, reached a high of 13.26 yuan, and a low of 12.26 yuan during the trading session [1] - The trading volume was 174,600 hands, with a total transaction amount of 225 million yuan [1] Management Changes - A recent announcement indicated a change in the company's continuous supervision representative, with Lin Suqin appointed to replace Fu Shubo due to the latter's job transfer [1] Capital Flow - On the trading day, the net outflow of main funds for Yirui Biotech was 490,300 yuan, with a cumulative net outflow of 34.71 million yuan over the past five trading days [1]